Search results
Results from the WOW.Com Content Network
The Kurtzke Expanded Disability Scale. The Kurtzke Expanded Disability Status Scale (EDSS) is a method of quantifying disability in multiple sclerosis. [1] [2] The scale has been developed by John F. Kurtzke. [1] The EDSS is based on a neurological examination by a clinician.
In particular, Dr Kurtzke is widely known for his Expanded Disability Status Scale or EDSS (a method of quantifying disability in multiple sclerosis) [2] and for his pioneering work in the field of neuroepidemiology, a branch of epidemiology he helped to establish in 1967 with Dr. Len Kurland and Dr. Milton Alter. [3]
The assessor requires little training for accurate completion and approximately fifteen minutes to score. The patient can perform the assessment retrospectively or it can be done using medical history. Secondly, the scale allows effective tracking of progress. [4] The scale is strongest and most sensitive in scaling general behavioral disability.
Ohio State was No. 1 in the final Associated Press Top 25 college football poll of the season Tuesday after beating Notre Dame for its first national championship since 2014. The Buckeyes (14-2 ...
The modified UPDRS retains the four-scale structure with a reorganization of the various subscales. Score ranges from 0 to 260, [7] [8] with 0 indicating no disability and 260 indicating total disability. The scales are: Part I: Nonmotor experiences of daily living: 13 items. Score range: 0–52, [8] 10 and below is mild, 22 and above is severe ...
Hints for Today's Connections Sports Edition Categories on February 20, 2025. Here are some hints about the four categories to help you figure out the word groupings.
Here’s how you can score tickets to the 2025 Blackpink world tour. Finance. Finance. Reuters. Chinese shares lift Asia, gold heads for eighth straight weekly gain. Finance. Business Insider.
The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It has become the most widely used clinical outcome measure for stroke clinical trials. [1] [2]